2026 年至 2032 年切片穿刺針市場（按產品類型、應用、程序、最終用戶和地區分類）

2026-2032年切片穿刺針市場評估

隨著癌症發病率的上升以及人們對早期檢測意識的增強，切片穿刺針市場正在迅速擴張。這些針頭用於採集組織樣本進行診斷測試。切片檢查技術的進步、人口老化加劇以及政府癌症宣傳舉措的加強是推動市場發展的主要因素。預計這些因素將推動市場規模在2024年突破103.6億美元，到2032年達到178.3億美元。

由於先進的醫療基礎設施和較高的癌症發病率，北美佔據了最大的市場佔有率。市場的主要企業包括Becton Dickinson & Company、Hologic, Inc.和Argon Medical Devices, Inc.。隨著對微創手術的需求不斷成長，該行業預計將繼續成長。切片穿刺針的需求不斷成長，使得市場在2026年至2032年間的複合年成長率達到7.02%。

切片穿刺針市場定義/概述

切片穿刺針是一種用於從體內取出組織樣本進行診斷的專用醫療器材。切片穿刺針針有很多不同的類型，包括芯針、細針和真空輔助針，每種類型都適用於特定的組織類型和診斷需求，尤其是癌症檢測。

切片穿刺針用於獲取組織樣本進行診斷檢測，有助於診斷和分析包括癌症在內的疾病。切片穿刺針提供了一種從身體各部位獲取細胞的微創方法，從而為診斷和治療計劃提供重要資訊。

隨著微創技術的發展、癌症診斷技術的進步以及人們對早期疾病檢測意識的提升，切片穿刺針在未來可能會變得更加普及。活體組織切片針技術的改進，例如精準度的提升和患者不適感的減輕，可能會加速其在臨床實踐中的應用。

人口老化加劇是否會推動切片穿刺針市場的成長？

人口老化預計將大幅推動切片穿刺針市場的發展。根據美國人口普查局的數據，到2030年，所有嬰兒潮世代都將年滿65歲或以上，老年人口總數將達到730億人。這群人更有可能需要針刺活體組織切片等診斷程序。

根據美國國家癌症美國的數據，約有39.5%的男性和女性在其一生中的某個階段會被診斷出患有癌症，診斷年齡中位數為66歲。美國疾病管制與預防中心報告稱，2018年新增癌症病例1,708,921例，癌症已成為65歲及以上人口的第二大死因。到2050年，美國65歲及以上人口預計將達到885億，這將進一步增加對切片穿刺針的需求。

切片檢查手術的高成本是否會阻礙切片穿刺針市場的發展？

切片檢查程序的高成本可能會限制切片穿刺針市場的成長。切片檢查程序（包括先進的成像技術和專用針頭）的成本對於某些個人和醫療保健系統來說可能過於昂貴，尤其是在資源匱乏的地區。

此外，高昂的費用可能會阻礙患者接受診斷性治療，尤其是在他們沒有完全醫療保險的情況下。這種負擔能力障礙可能會限制重要的診斷檢測，導致診斷和治療延誤。雖然技術發展和癌症等疾病的流行將推動切片穿刺針的需求，但治療成本可能會限制市場發展。降低價格和增加醫療保健可近性的措施可能有助於緩解這些問題並擴大市場。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

第4章切片穿刺針市場（按產品類型）

• 切片穿刺針
• 吸痰針

第5章切片穿刺針市場（按應用）

• 腫瘤/癌症應用
• 傷口應用

第6章切片穿刺針市場（按程序）

• 影像導引手術
• 非影像導引手術

切片穿刺針市場（按最終用戶分類）

• 醫院和外科中心
• 診斷診所和病理實驗室
• 門診醫療中心
• 研究和學術機構

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市場佔有率分析

第10章 公司簡介

• Becton
• Medtronic plc
• Boston Scientific Corporation
• FUJIFILM Holdings Corporation
• Dickinson & Company（BD）
• Becton
• Cardinal Health
• Hologic, Inc.
• Olympus Corporation
• Argon Medical Devices, Inc.
• Devicor Medical Products, Inc.
• Braun Melsungen AG
• Cook Group Incorporated

第11章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Biopsy Needles Market Valuation - 2026-2032

The Biopsy Needles Market is expanding rapidly due to the rising prevalence of cancer and increasing awareness of early detection. These needles are required for collecting tissue samples for diagnostic testing. Technological advancements in biopsy techniques, a growing aging population and increasing government cancer awareness initiatives are among the key market drivers. This is likely to enable the market size surpass USD 10.36 Billion valued in 2024 to reach a valuation of around USD 17.83 Billion by 2032.

North America possesses the largest market share due to advanced healthcare infrastructure and high cancer incidence rates. Key players in the market include companies like Becton, Dickinson and Company, Hologic, Inc. and Argon Medical Devices. The industry is likely to continue rising as demand for minimally invasive procedures increases. The rising demand for Biopsy Needles is enabling the market grow at a CAGR of 7.02% from 2026 to 2032.

Biopsy Needles Market: Definition/ Overview

Biopsy needles are specialist medical devices that collect tissue samples from the body for diagnostic purposes. They come in a variety of styles, including core, fine and vacuum-assisted needles, each suited for a specific tissue type and diagnostic necessity, particularly in cancer detection.

Biopsy needles are used to collect tissue samples for diagnostic testing, which aids in the diagnosis and analysis of diseases, including cancer. They provide a minimally invasive way for collecting cells from diverse bodily areas, thereby providing critical information for diagnosis and treatment planning.

Biopsy needles will most likely be used more in the future as minimally invasive techniques evolve, cancer diagnoses improve and awareness of early illness detection grows. Improved needle technologies, such as increasing precision and less patient discomfort, will accelerate their use in medical practices.

Will Growing Aging Population to Boost the Biopsy Needles Market Growth?

The growing aging population is expected to significantly boost the biopsy needle market. According to the US Census Bureau, by 2030, all baby boomers will be over the age of 65, bringing the total number of older people to 73 Billion. This demographic is more likely to require diagnostic procedures like needle biopsy.

According to the National Cancer Institute, approximately 39.5% of men and women will be diagnosed with cancer at some point during their lifetimes, with the median age for diagnosis being 66 years. The CDC reported 1,708,921 new cancer cases in 2018, with cancer being the second leading cause of death among those aged 65 and older. By 2050, the number of Americans aged 65 and older is predicted to reach 88.5 Billion, further raising need for biopsy needles.

Will High Cost of Biopsy Operations Hamper the Biopsy Needles Market?

The high cost of biopsy surgeries may limit the growth of the biopsy needles market. The costs of biopsy treatments, such as advanced imaging techniques and specialized needles, might be too expensive for some individuals and healthcare systems, especially in areas with low healthcare financing.

Furthermore, high costs may discourage patients from pursuing diagnostic treatments, particularly in the absence of full insurance coverage. This price barrier can limit access to important diagnostic testing, potentially resulting in delayed diagnosis and treatment. While technical developments and the rising prevalence of diseases such as cancer fuel demand for biopsy needles, the market's expansion may be limited by the cost of treatments. Efforts to cut prices and enhance healthcare access could help to mitigate these issues and expand the market.

Category-Wise Acumens

Will Increasing Need for Early and Accurate Diagnosis Drive the Application Segment?

The growing demand for early and precise diagnosis is a major driver in the biopsy needles application area. Early diagnosis of diseases such as cancer is critical to improve treatment outcomes and survival rates. Biopsy needles are essential for collecting tissue samples for definitive diagnosis, as they aid in determining the presence and stage of illnesses. As healthcare systems prioritize preventive care and precision medicine, the demand for improved diagnostic instruments, such as biopsy needles, increases.

Furthermore, technical advances in biopsy needle design and imaging techniques improve the accuracy and safety of treatments. The rising emphasis on early diagnosis and individualized treatment strategies is projected to drive biopsy needle utilization and market growth.

Will Increasing Demand for Greater Accuracy and Precision in Locating and Sampling Tissues Drive the Procedure Segment?

The growing demand for improved accuracy and precision in locating and sampling tissues is a major driver in the image-guided biopsy procedures market. Image-guided techniques, which use technologies such as ultrasound, CT, or MRI, improve the precision of biopsies by allowing for real-time viewing of target locations. This lowers the likelihood of sampling errors, complications and the need for repeat treatments, ultimately increasing diagnostic accuracy and patient outcomes.

As healthcare professionals and consumers seek more reliable and minimally invasive diagnostic approaches, image-guided biopsies are becoming increasingly popular. This tendency is bolstered by technology advances in imaging and needle design, which make these treatments safer and more efficient. As a result, the demand for image-guided biopsy treatments is likely to rise, boosting the total market for biopsy needles.

Country/Region-wise Acumens

Will High Prevalence of Cancer Drive the Market in North America?

The rising rate of cancer is driving the demand for biopsy needles in North America. With cancer being one of the main causes of mortality in the region, there is a significant emphasis on early identification and correct diagnosis, both of which are critical for effective treatment and improved patient outcomes. North America's well-established healthcare system, combined with extensive access to improved diagnostic tools, makes biopsy needles useful for identifying many malignancies.

Furthermore, a growing understanding of the necessity of regular screenings and early detection contributes to the rising demand for biopsy treatments. Supportive government initiatives and healthcare policies also contribute to industry growth. Consequently, the high cancer prevalence is a crucial element driving the rise of the biopsy needles market in North America.

Will Increasing Healthcare Investments Drive the Market in Asia Pacific Region?

Increasing healthcare investments are a key driver of the Asia-Pacific biopsy needles market. As countries in this region improve their healthcare infrastructure, there is a greater emphasis on strengthening diagnostic skills and increasing access to innovative medical technologies. Governments and business sectors are investing in updating hospitals, clinics and diagnostic centers, increasing the availability of biopsy procedures. This investment also helps healthcare professionals' training in the use of sophisticated diagnostic technologies, which will help to drive market growth.

Furthermore, greater knowledge about early illness detection, combined with an aging population and an increasing prevalence of cancer, drives up demand for biopsy needles. As healthcare systems in Asia-Pacific improve, the market for biopsy needles is likely to rise, driven by these significant investments and the growing emphasis on quality healthcare.

Competitive Landscape

The biopsy needles market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the biopsy needles market include:

Becton

Medtronic plc

Boston Scientific Corporation

FUJIFILM Holdings Corporation

Dickinson & Company (BD)

Becton

Cardinal Health

Hologic, Inc.

Olympus Corporation

Argon Medical Devices, Inc.

Devicor Medical Products, Inc.

Braun Melsungen AG

Cook Group Incorporated

Latest Developments

In November 2022, Cambridge Enterprise released the Cambridge Prostate Biopsy Device (CamPROBE) to minimize infection risk during transrectal biopsies. This unique device includes an integrated needle for localized anesthetic delivery.

In August 2022, Mammotome launched its Mammotome DualCore biopsy system, making its debut in the dual-stage core biopsy equipment market. The device's lightweight, ergonomic and clever design minimizes needle movements and vibrations while improving the entire patient experience.

Biopsy Needles Market, By Category

• Product Type:
• Biopsy Needles
• Aspiration Needles
• Application:
• Tumor/Cancer Applications
• Wound Applications
• Procedure:
• Image-guided Procedures
• Non-image-guided Procedures
• End-User:
• Hospitals & Surgical Centers
• Diagnostic Clinics & Pathology Laboratories
• Ambulatory Care Centers
• Research & Academic Institutes
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Biopsy Needles Market, By Product Type

• Biopsy Needles
• Aspiration Needles

5. Biopsy Needles Market, By Application

• Tumor/Cancer Applications
• Wound Applications

6. Biopsy Needles Market, By Procedure

• Image-guided Procedures
• Non-image-guided Procedures

Biopsy Needles Market, By End-User

• Hospitals & Surgical Centers
• Diagnostic Clinics & Pathology Laboratories
• Ambulatory Care Centers
• Research & Academic Institutes

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Becton
• Medtronic plc
• Boston Scientific Corporation
• FUJIFILM Holdings Corporation
• Dickinson & Company (BD)
• Becton
• Cardinal Health
• Hologic, Inc.
• Olympus Corporation
• Argon Medical Devices, Inc.
• Devicor Medical Products, Inc.
• Braun Melsungen AG
• Cook Group Incorporated

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References